3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Conditions
Leukemia, Myeloid, Acute
19
Lymphoma
17
Lymphoma, Large B-Cell, Diffuse
15
Precursor Cell Lymphoblastic Leukemia-Lymphoma
14
Lymphoma, Non-Hodgkin
14
Hodgkin Disease
13
Multiple Myeloma
12
Lymphoma, Mantle-Cell
12
Lymphoma, Follicular
12
Carcinoma, Non-Small-Cell Lung
11
Breast Neoplasms
11
Leukemia, Lymphocytic, Chronic, B-Cell
9
Glioblastoma
9
Lymphoma, B-Cell, Marginal Zone
8
Burkitt Lymphoma
8
Brain Neoplasms
8
Sezary Syndrome
7
Neoplasms
7
Lymphoma, T-Cell, Cutaneous
7
Leukemia
7
Congenital Abnormalities
7
Unspecified Adult Solid Tumor, Protocol Specific
6
Recurrence
6
Neuroblastoma
6
Mycosis Fungoides
6
Lymphoma, Large-Cell, Immunoblastic
6
Lymphoma, Large-Cell, Anaplastic
6
Breast Neoplasms, Male
6
Sarcoma
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Interventions
Fluorouracil
12
Radiotherapy
8
Cisplatin
8
pembrolizumab
4
Papillomavirus Vaccines
4
Mitomycin
4
Irinotecan
4
Cyclophosphamide
4
Cetuximab
4
Light Coagulation
3
Interleukin-12 Subunit p35
3
Capecitabine
3
fludarabine phosphate
2
fludarabine
2
atezolizumab
2
aldesleukin
2
Watchful Waiting
2
Vaccines
2
Trastuzumab
2
Surveys and Questionnaires
2
Radiation
2
Quality of Life
2
Paclitaxel
2
Oxaliplatin
2
Erlotinib Hydrochloride
2
Early Intervention, Educational
2
Carboplatin
2
Biopsy
2
toripalimab
1
tipifarnib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Anus Neoplasms
×
Vorinostat
×
Clear all
NCT04357873
2025-02-19
PEVOsq
UNICANCER
Phase 2
Completed
112 enrolled